Table 1.

BMPs inhibit oligodendrocyte development in ventral neural tube explants

Number of O4+ cells per culture*
Treatment
Co-cultures with Q2bn cells
Developmental stageNo BMP4With BMP4Control cellsBMP2-producing cells
E1.5 MNP plus 3 days in vitro 120±40 (n=3) 6±4 (n=3) 777±313 (n=5) 7±5 (n=5) 
E4.5 VNT§ 656±128 (n=4) 199±66 (n=4) 910±319 (n=4) 181±87 (n=4) 
Number of O4+ cells per culture*
Treatment
Co-cultures with Q2bn cells
Developmental stageNo BMP4With BMP4Control cellsBMP2-producing cells
E1.5 MNP plus 3 days in vitro 120±40 (n=3) 6±4 (n=3) 777±313 (n=5) 7±5 (n=5) 
E4.5 VNT§ 656±128 (n=4) 199±66 (n=4) 910±319 (n=4) 181±87 (n=4) 

n, number of independent culture experiments.

E1.5 medial neural plate explants aged for 3 days in vitro or E4.5 ventral neural tube explants were cultivated in the absence or presence of human recombinant BMP4 protein (0.6 nM), or co-cultured with Q2bn control cells or Q2bn-BMP2-producing cells. Medial neural plate explants were grown for 4 days and ventral neural tube explants were grown for 7 days. Fixed cultures were then stained with O4 antibody and developing oligodendrocytes were counted.

*

Mean±s.e.m.

MNP, medial neural plate cultures (four to eight explants per culture).

§

VNT: ventral neural tube cultures (40 explants per culture).

Close Modal

or Create an Account

Close Modal
Close Modal